Antisense Inhibition of the RAD51 Enhances Radiosensitivity

By Taki T.   Ohnishi T.   Yamamoto A.   Hiraga S.   Arita N.   Izumoto S.   Hayakawa T.   Morita T.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 2, 1996-06 ,pp. : 434-438

Elsevier

Access to resources Recommend Favorite

In Vivo Inhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate Oligonucleotides

By Moriya K.   Matsukura M.   Kurokawa K.   Koike K.  

Biochemical and Biophysical Research Communications, Vol. 218, Iss. 1, 1996-01 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Myotonic Dystrophy: Antisense Oligonucleotide Inhibition of DMPK Gene Expression in Vitro

By Galderisi U.   Cipollaro M.   Melone M.A.B.   Iacomino G.   Di Bernardo G.   Galano G.   Contrufo R.   Zappia V.   Cascino A.  

Biochemical and Biophysical Research Communications, Vol. 221, Iss. 3, 1996-04 ,pp. : 750-754

Elsevier

Access to resources Recommend Favorite

Genetic re‐engineering of Saccharomyces cerevisiae RAD51 leads to a significant increase in the frequency of gene repair in vivo

By Liu Li   Maguire Katie K.   Kmiec Eric B.  

Nucleic Acids Research, Vol. 32, Iss. 7, 2004-04 ,pp. : 2093-2101

Oxford University Press

Access to resources Recommend Favorite

Urokinase Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Malignant Glioma: In Vitro and in Vivo Studies of Uptake, Effects and Toxicity

By Engelhard H.   Narang C.   Homer R.   Duncan H.  

Biochemical and Biophysical Research Communications, Vol. 227, Iss. 2, 1996-10 ,pp. : 400-405

Elsevier

Access to resources Recommend Favorite